Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Number of holders
-
155
-
Total 13F shares, excl. options
-
26,837,854
-
Shares change
-
-352,067
-
Total reported value, excl. options
-
$1,392,008,743
-
Value change
-
-$12,404,048
-
Put/Call ratio
-
12.5%
-
Number of buys
-
59
-
Number of sells
-
-74
-
Price
-
$51.23
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q2 2016
174 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q2 2016.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 155 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26,837,854 shares
of 834,731,296 outstanding shares and own 3.22% of the company stock.
Largest 10 shareholders include Fisher Asset Management, LLC (5,227,024 shares), COMMONWEALTH BANK OF AUSTRALIA (3,171,326 shares), AQR CAPITAL MANAGEMENT LLC (2,942,929 shares), ROYAL BANK OF CANADA (2,078,604 shares), VANGUARD GROUP INC (1,427,966 shares), VONTOBEL ASSET MANAGEMENT INC (1,270,516 shares), BlackRock Group LTD (917,533 shares), DIMENSIONAL FUND ADVISORS LP (644,089 shares), STATE STREET CORP (534,461 shares), and NORTHERN TRUST CORP (517,251 shares).
This table shows the top 155 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.